A protocol has been prepared for conducting a phase II study of the effectiveness of the drug
18 January 2021
A protocol has been prepared for conducting a phase II comparative study of the efficacy and safety of different dosages of the drug in sequential therapy in patients with primary open-angle glaucoma.